Romain Cohen

Sorbonne Université

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

LinkedIn

Google Scholar

Articles (22)

A 2023 inventory in oncology news

Year:

2024

A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability

Year:

2024

A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trial

Year:

2024

An update on total neoadjuvant treatment of adenocarcinoma of the rectum

Year:

2024

Deficient mismatch repair/microsatellite unstable colorectal cancer: therapeutic advances and questions

Year:

2024

Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation

Year:

2024

Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients

Year:

2024

Microsatellite instability at U2AF-binding polypyrimidic tract sites perturbs alternative splicing during colorectal cancer initiation

Year:

2024

Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR)

Year:

2024

Performances of preoperative CT scan to predict the pTN stage for MSI/ dMMR localized colon cancers

Year:

2024

Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis

Year:

2024

Claudine 18.2: A new therapeutic target in digestive cancers

Year:

2024

BRAF (V600E)/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors

Year:

2023

Designing Trials for Neoadjuvant Immune Checkpoint Inhibition in Microsatellite Instability-High Localized Colorectal Cancer

Year:

2023

Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study

Year:

2023

Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database

Year:

2023

First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial

Year:

2023

Immune checkpoint inhibitors for patients with isolated peritoneal carcinomatosis from dMMR/MSI-H colorectal cancer, a BIG-RENAPE collaboration

Year:

2023

Impact of mismatch repair deficiency on tumour regression grade after neoadjuvant chemotherapy in localized gastroesophageal adenocarcinoma

Year:

2023

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study

Year:

2023

Original Research Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naive metastatic colorectal cancer. An AGEO prospective study

Year:

2023

Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade

Year:

2023

Collaborators (4)

Thierry André

Sorbonne Université

FRANCE

david tougeron

-

FRANCE

Greg Yothers

Research Professor

University of Pittsburgh

UNITED STATES

Guillaume Piessen

-

FRANCE

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI